SEC 13F Intelligence

Managers / Q4 2023 · view latest →

BROADWOOD CAPITAL INC

CIK 0001278387 · 156 WEST 56TH STREET, 3RD FLOOR, NEW YORK, NY, 10019 · 212-508-5735

Reported Value
$1.2B
Q4 2023
Positions
7
Filings on Record
30
2019–present window
Filed
Feb 14, 2024
original filing

Summary

Broadwood Capital Inc reported $1.2B in U.S.-listed holdings across 7 positions for Q4 2023.

The portfolio is heavily concentrated: MNST alone accounts for 41.7% of reported value.

The book was largely unchanged from Q3 2023.

Portfolio Metrics

Turnover
+4.3%
vs prior filed quarter
Largest Position
+41.7%
Monster Beverage

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $713MQ4 ’18Q1 ’19: $817MQ2 ’19: $800MQ3 ’19: $720MQ4 ’19: $867MQ4 ’19Q1 ’20: $856MQ2 ’20: $1.3BQ3 ’20: $1.3BQ4 ’20: $1.7BQ4 ’20Q1 ’21: $1.9BQ2 ’21: $2.2BQ3 ’21: $2.0BQ4 ’21: $1.6BQ4 ’21Q1 ’22: $1.4BQ2 ’22: $1.3BQ3 ’22: $1.3BQ4 ’22: $1.2BQ4 ’22Q1 ’23: $1.4BQ2 ’23: $1.3BQ3 ’23: $1.1BQ4 ’23: $1.2BQ4 ’23Q1 ’24: $1.3BQ2 ’24: $1.3BQ3 ’24: $1.3BQ4 ’24: $1.3BQ4 ’24Q1 ’25: $1.2BQ2 ’25: $1.6BQ3 ’25: $1.7BQ4 ’25: $1.7BQ4 ’25Q1 ’26: $1.4Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 90.3%ETP: 9.7%
  • Common Stock · 90.3% · $1.1B
  • ETP · 9.7% · $114M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
STAASTAAR SURGICAL COADDED+1.27M10.54M−$43M$329M
MNSTMONSTER BEVERAGE CORP NEWHELD−13.2K8.49M+$39M$489M
AXONAXON ENTERPRISE INCHELD+0760.1K+$45M$196M
ISHARES TRHELD+0566.0K+$14M$114M
LCTXLINEAGE CELL THERAPEUTICS INHELD+034.94M−$3M$38M
IMDXONCOCYTE CORPHELD+02.51M−$2M$6M
AGEGBPAGEX THERAPEUTICS INCHELD+03.00M−$884,161$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2023

7 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1MNSTMONSTER BEVERAGE CORP NEWhistory →COM41.68%$489M8.49M
2STAASTAAR SURGICAL COhistory →COM PAR $0.0128.03%$329M10.54M
3AXONAXON ENTERPRISE INChistory →COM16.73%$196M760.1K
4ISHARES TRRUSSELL 2000 ETF9.68%$114M566.0K
5LCTXLINEAGE CELL THERAPEUTICS INhistory →COM3.25%$38M34.94M
6IMDXONCOCYTE CORPCOM NEW0.53%$6M2.51M
7AGEGBPAGEX THERAPEUTICS INCCOM0.10%$1M3.00M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$1.4B6May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$1.7B12Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$1.7B12Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$1.6B13Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$1.2B8May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$1.3B7Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$1.3B7Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$1.3B7Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$1.3B7May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$1.2B7Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$1.1B7Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$1.3B7Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.4B7May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.2B7Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.3B8Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.3B8Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.4B7May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.6B7Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$2.0B7Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$2.2B7Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.9B8May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.7B8Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B7Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.3B7Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$856M7May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$867M7Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$720M7Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$800M7Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$817M7May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$713M8Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • BROADWOOD PARTNERS, L.P.028-13770

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.